ASCO

Trending

Microplastics in intravenous infusions: emerging health concerns for medical practitioners
Interval breast cancer: understanding risks and the need for enhanced screening
Prostate cancer and erectile function: NeuroSAFE technique enhances postoperative outcomes in robot-assisted radical prostatectomy
Sign Up for The Oncology Newsletter | Our free weekly news roundup
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
ASCO 2026: Fasting before and after chemo may help improve treatment response for some people with ovarian cancer
ASCO 2026: Less cognitive decline with darolutamide treatment than enzalutamide in people with advanced prostate cancer
ASCO 2026: Trial tests virus-immunotherapy combination for neuroendocrine tumours
ASCO 2026: New AI tool may help personalise multiple myeloma treatment

RSS
Facebook
Twitter
LinkedIn

Navigate

Featured
Podcasts
Focus
Tumour
Industry
Contact
More

Featured
Podcasts
Focus
Tumour
Industry
Contact
More

You are at:Home » Events » (Page 15)

Browsing: ASCO

ASCO

ASCO 2022: Open-label placebo treatment reduces cancer-related fatigue in patients with advanced cancers

June 2, 2022

Cancer-related fatigue (CRF) is the most common symptom in patients with cancer, and there are limited…

ASCO

ASCO 2022: Follow-up data further support the superior efficacy of cabozantinib in patients with progressive differentiated thyroid cancer

June 2, 2022

To be presented at the American Society of Clinical Oncology’s (ASCO) Annual Meeting, 03 – 07 June…

ASCO

ASCO GU 2022: Enfortumab vedotin is effective in patients with aggressive bladder cancer

February 25, 2022

Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in…

ASCO

ASCO GU 2022: Biomarker may help predict survival in patients with bladder cancer

February 21, 2022

Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive…

ASCO

ASCO GU 2022: New genetic risk score stratifies lifetime risk of dying of prostate cancer in diverse populations

February 21, 2022

A new study suggests that an extensive genetic risk score could be an effective tool…

Previous 1 … 13 14 15

FEATURED EVENT: GI CANCER TRIALS ASM
LATEST PODCASTS

Nothing Found

Apologies, but no results were found for the requested archive. Perhaps searching will help find a related post.

About Us

Oncology News Australia is a small group of publishing, media and digital professionals providing resources for the oncology community. More information.
Subscribe for News Updates

The Oncology Newsletter is a free publication distributed to healthcare professionals every week, featuring news, views, reviews and the latest jobs. Subscribe.
Advertising with Us

If you seek to connect and present your product or service to an engaged oncology healthcare community, you have come to the right place. More information.

ACKNOWLEDGEMENT OF COUNTRY

We respectfully acknowledge the Traditional Custodians of the land on which we operate and gather. We honour their deep and enduring connection to the land, waters and skies, and pay our respects to Elders past, present and emerging.

We recognise the invaluable contributions of Aboriginal and Torres Strait Islander peoples to the health and wellbeing of our community. We acknowledge the significant disparities in health outcomes between Indigenous and non-Indigenous Australians and are devoted to playing our part in closing this gap. We pledge to continually learn from and with Aboriginal and Torres Strait Islander communities, striving for a future where health equity is a reality.